Valuation Ind-Swift Laboratories Limited

Stocks

Delayed NSE India S.E. Other stock markets 11:16:36 12/06/2026 +04			5-day change	1st Jan Change
163.00 ^INR	+2.75%		+3.26%	+85.08%

05-28	Ind-Swift Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026	CI
04-07	Ind Swift Laboratories says tribunal rejected all claims of PI Industries, counterclaims of co, others	RE

Data adjusted to current consolidation scope

Fiscal Period: March	2020	2021	2022	2023	2024	2025
Market Cap ¹	1,202	4,251	3,938	3,262	5,918	4,961
Change	-	253.56%	-7.37%	-17.18%	81.43%	-16.17%
Enterprise Value (EV) ¹	11,410	14,189	13,254	11,701	1,764	695.5
Change	-	24.36%	-6.59%	-11.72%	-84.92%	-60.59%
P/E Ratio	-4.75x	-135x	-183x	6.85x	1.41x	2.38x
PBR	0.19x	0.7x	0.66x	0.48x	0.64x	0.49x
PEG	-	1.5x	5.8x	-0x	0x	-0x
Capitalization / Revenue	0.15x	0.47x	0.37x	0.27x	0.46x	0.88x
EV / Revenue	1.43x	1.56x	1.26x	0.96x	0.14x	0.12x
EV / EBITDA	8.88x	8.54x	5.96x	4.9x	0.66x	-3.19x
EV / EBIT	15.4x	12.8x	14.3x	6.45x	0.82x	-1.59x
EV / FCF	46.6x	58x	49.3x	26.6x	0.18x	-0.33x
FCF Yield	2.15%	1.72%	2.03%	3.76%	558%	-302%
Dividend per Share ²	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-
EPS ²	-4.284	-0.5326	-0.3637	8.055	71.24	35.21
Distribution rate	-	-	-	-	-	-
Net sales ¹	7,993	9,068	10,521	12,159	12,973	5,617
EBITDA ¹	1,285	1,661	2,224	2,389	2,683	-217.8
EBIT ¹	739.6	1,110	924.1	1,815	2,150	-438.6
Net income ¹	-211.9	-31.47	-21.49	476	4,210	2,505
Net Debt ¹	10,207	9,938	9,315	8,439	-4,153	-4,265
Reference price ²	20.35	71.95	66.65	55.20	100.15	83.96
Nbr of stocks (in thousands)	59,087	59,087	59,087	59,087	59,087	59,087
Announcement Date	07/09/20	07/09/21	07/09/22	05/09/23	06/09/24	05/09/25

¹INR in Million²INR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
IND-SWIFT LABORATORIES LIMITED	-	-	-	-	144M
SUN PHARMACEUTICAL INDUSTRIES LTD.	37.01x	7x	23.88x	0.84%	44.96B
OTSUKA HOLDINGS CO., LTD.	17.02x	1.9x	8.99x	1.43%	33.53B
CIPLA LIMITED	26.7x	3.28x	16.8x	0.9%	11.67B
ZYDUS LIFESCIENCES LIMITED	24.25x	4.23x	15.77x	0.73%	11.62B
KRKA, D. D.	19.34x	3.34x	12.18x	3.51%	8.97B
GEDEON RICHTER	8.14x	1.9x	4.98x	5.33%	6.89B
ONO PHARMACEUTICAL CO., LTD.	14.75x	1.94x	7.33x	3.63%	6.55B
GLENMARK PHARMACEUTICALS LIMITED	32.55x	3.7x	15.73x	0.25%	6.32B
SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD.	41.52x	-	-	-	5.12B
Average	24.59x	3.41x	13.21x	2.08%	13.58B
Weighted average by Cap.	26.34x	4.18x	15.67x	1.52%